<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP15797815B8W1" file="EP15797815W1B8.xml" lang="en" country="EP" doc-number="3218397" kind="B8" correction-code="W1" date-publ="20210407" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>BDM Ver 1.7.2 (20 November 2019) -  2999001/0</B007EP></eptags></B000><B100><B110>3218397</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20210407</date></B140><B150><B151>W1</B151><B153>72</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>15797815.6</B210><B220><date>20151113</date></B220><B240><B241><date>20170605</date></B241><B242><date>20180302</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>201462080094 P</B310><B320><date>20141114</date></B320><B330><ctry>US</ctry></B330><B310>201462087087 P</B310><B320><date>20141203</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20210407</date><bnum>202114</bnum></B405><B430><date>20170920</date><bnum>201738</bnum></B430><B450><date>20210224</date><bnum>202108</bnum></B450><B452EP><date>20200930</date></B452EP><B480><date>20210407</date><bnum>202114</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07K  16/10        20060101AFI20160526BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>NEUTRALISIERENDE ANTIKÖRPER GEGEN EBOLA VIRUS GLYKOPROTEIN UND DEREN VERWENDUNG</B542><B541>en</B541><B542>NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE</B542><B541>fr</B541><B542>ANTICORPS NEUTRALISANTS CONTRE EBOLA GLYCOPROTEIN ET LEUR UTILISATION</B542></B540><B560><B561><text>WO-A2-2004/018649</text></B561><B561><text>WO-A2-2011/071574</text></B561><B562><text>XIANGGUO QIU ET AL: "Characterization ofglycoprotein-specific monoclonal antibodies", CLINICAL IMMUNOLOGY, ACADEMIC PRESS, US, vol. 141, no. 2, 13 August 2011 (2011-08-13), pages 218-227, XP028322702, ISSN: 1521-6616, DOI: 10.1016/J.CLIM.2011.08.008 [retrieved on 2011-08-31]</text></B562><B562><text>LEE J E ET AL: "Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it", CURRENT OPINION IN STRUCTURAL BIOLOGY, ELSEVIER LTD, GB, vol. 19, no. 4, 1 August 2009 (2009-08-01) , pages 408-417, XP026541929, ISSN: 0959-440X, DOI: 10.1016/J.SBI.2009.05.004 [retrieved on 2009-06-24]</text></B562></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>21158309.1</anum></dnum><date>20210220</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>CORTI, Davide</snm><adr><str>Humabs Biomed SA
Via Mirasole 1</str><city>CH-6500 Bellinzona</city><ctry>CH</ctry></adr></B721><B721><snm>LANZAVECCHIA, Antonio</snm><adr><str>Va Vincenzo Vela 6</str><city>CH-6500 Bellinzona</city><ctry>CH</ctry></adr></B721><B721><snm>TREFRY, John</snm><adr><str>Usamriid
1425 Porter Street
Frederick</str><city>MD 210702</city><ctry>US</ctry></adr></B721><B721><snm>SULLIVAN, Nancy</snm><adr><str>Nih/niaid. Building 40
40 Convent Dr.
Bethesda</str><city>MD 20892</city><ctry>US</ctry></adr></B721><B721><snm>MULANGU, Sabue</snm><adr><str>Nih/niaid. Building 40
40 Convent Dr.
Bethesda</str><city>MD 20892</city><ctry>US</ctry></adr></B721><B721><snm>GRAHAM, Barney</snm><adr><str>Nih/niaid
Building 40
40 Convent Dr.
Bethesda</str><city>MD 20892</city><ctry>US</ctry></adr></B721><B721><snm>MUYEMBE-TAMFUN, Jean-Jacques</snm><adr><str>National Institute for Biomedical Research
Avenue of Democracy
Kinshasa-Gombe B.P. 1197</str><city>Kinshasa</city><ctry>CG</ctry></adr></B721><B721><snm>LEDGERWOOD, Julie</snm><adr><str>Nih/niaid
Building 40
40 Convent Dr.</str><city>Bethesda, MD 20892</city><ctry>US</ctry></adr></B721><B721><snm>STANLEY, Daphne</snm><adr><str>NIH/NIAID
Building 40
40 Convent Dr.</str><city>Bethesda, MD 20892</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>The United States Of America, As Represented 
By The Secretary, Department Of Health 
And Human Services</snm><iid>101449765</iid><irf>4650P/EP</irf><adr><str>National Institutes of Health 
Office of Technology Transfer 
6011 Executive Boulevard 
Suite 325 
MSC 7660</str><city>Bethesda, MD 20852-7660</city><ctry>US</ctry></adr></B731><B731><snm>The United States Government, as represented 
by The Secretary of The Army</snm><iid>101279929</iid><irf>4650P/EP</irf><adr><str>504 Scott Street</str><city>Fort Detrick, MD 21702</city><ctry>US</ctry></adr></B731><B731><snm>Humabs Biomed S.A.</snm><iid>101412623</iid><irf>4650P/EP</irf><adr><str>Via Mirasole 1</str><city>6500 Bellinzona</city><ctry>CH</ctry></adr></B731><B731><snm>Institute for Research in Biomedicine</snm><iid>101228166</iid><irf>4650P/EP</irf><adr><str>Via Vincenzo Vela 6</str><city>6500 Bellinzona</city><ctry>CH</ctry></adr></B731></B730><B740><B741><snm>Docherty, Robert Charles</snm><iid>101494268</iid><adr><str>Symbiosis IP Limited 
York Biotech Campus 
Office 14FA05 
Sand Hutton</str><city>York, YO41 1LZ</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2015060733</anum></dnum><date>20151113</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2016077789</pnum></dnum><date>20160519</date><bnum>201620</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
